SCHEMBL125004

SCHEMBL125004

CCC(CCO)C(O)(O)CCO

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18577822 1.00 DPP4 (0.39) DPP4
SCHEMBL855390 0.77 DPP4 (0.43) DPP4
SCHEMBL14840410 0.76 DPP4 (0.39) DPP4
SCHEMBL5931169 0.75 DPP4 (0.42) DPP4
SCHEMBL30073234 0.74 DPP4 (0.37) DPP4
Ammonia Solution, Strong SCHEMBL20450561 0.73 DPP4 (0.40) DPP4
SCHEMBL28658093 0.73 FDPS (0.31)
SCHEMBL14193389 0.72 DPP4 (0.43) DPP4
Ammonia Solution, Strong SCHEMBL20450613 0.71 DPP4 (0.39) DPP4
SCHEMBL28231490 0.70 DPP4 (0.42) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3514189-B1 SOLVENT-FREE MULTICOMPONENT SYSTEM EVONIK OPERATIONS GMBH (DE) 2023-07-26 EP claimed
EP-3514189-A1 SOLVENT-FREE MULTICOMPONENT SYSTEM Evonik Degussa GmbH (DE) 2019-07-24 EP claimed
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials EVONIK DEGUSSA GMBH (DE) 2019-07-02 US claimed
US-10336854-B2 Alkoxysilane-functionalized and allophanate-functionalized urethanes EVONIK DEGUSSA GMBH (DE) 2019-07-02 US claimed
US-20170369631-A1 ALKOXYSILANE- AND ALLOPHANATE-FUNCTIONALIZED COATING MATERIALS EVONIK DEGUSSA GMBH (DE) 2017-12-28 US claimed
US-20170369627-A1 ALKOXYSILANE-FUNCTIONALIZED AND ALLOPHANATE-FUNCTIONALIZED URETHANES EVONIK DEGUSSA GMBH (DE) 2017-12-28 US claimed
US-20160152825-A1 PROCESS FOR PRODUCING COMPOSITES EVONIK DEGUSSA GMBH (DE) 2016-06-02 US claimed
EP-2488567-B1 PROCESS FOR MAKING POLYESTER OR COPOLYESTER FROM LACTONES EVONIK DEGUSSA GMBH (DE) 2015-05-06 EP claimed
EP-2162483-B1 POLYESTERS CONTAINING AMINO GROUPS EVONIK DEGUSSA GMBH (DE) 2014-05-14 EP claimed
US-20130289154-A1 RADIATION-CURABLE FORMULATION WHICH FORMS FLEXIBLE COATINGS WITH INCREASED CORROSION PROTECTION ON METALLIC SUBSTRATES EVONIK DEGUSSA GMBH (DE) 2013-10-31 US claimed
US-20080146728-A1 Radiation Curable Composition Consisting of Unsaturated Amorphous Polyesters and Reactive Dilutant Agents DEGUSSA AG (DE) 2008-06-19 US claimed
US-20080027156-A1 Polymer Compositions of Carbonyl-Hydrated Ketone-Aldehyde Resins and Polyisocyanates in Reactive Solvents DEGUSSA AG (DE) 2008-01-31 US claimed
US-6930155-B2 Powder coatings based on thermoset-modified polymers and polyesters DEGUSSA AG (DE) 2005-08-16 US claimed
US-20040014855-A1 Transparent or pigmented powder coatings based on certain carboxyl-containing polyesters with hydroxyalkylamides and use thereof DEGUSSA AG (DE) 2004-01-22 US claimed
EP-1382645-A1 Transparent or pigmented powder coatings based on particular carboxy-group-containing polyesters and hydroxyalkylamides and their application Degussa AG (DE) 2004-01-21 EP claimed
EP-1362871-A1 Process for the solventless, continuous preparation of a composition of polymers and thermosets Degussa AG (DE) 2003-11-19 EP claimed
EP-1362873-A1 Powder coatings based on polyesters and thermoset modified polyesters Degussa AG (DE) 2003-11-19 EP claimed
US-20030212206-A1 Polymeric composition prepared from polymers and thermosets DEGUSSA AG (DE) 2003-11-13 US claimed
US-20030212207-A1 Process for the solvent-free continuous preparation of a polymeric composition prepared from polymers and thermosets DE GUSSA AG (DE) 2003-11-13 US claimed
EP-1361237-A1 Preparation of polymers and thermosets Degussa AG (DE) 2003-11-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials DDAH1, OR10J3, AP3S1 DPP4 3338/4885
US-10336854-B2 Alkoxysilane-functionalized and allophanate-functionalized urethanes ALKBH3, PUF60, SDC2 DPP4 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.